Vascular Discovery Scientic Sessions 2025  /  07. Concurrent Session 2b: Metabolism in Cardiovascular Disease  /  Unveiling Novel Hepatic Metabolic Pathways as Dual Targets for MASH and Atherosclerosis Treatment
Logo

American Heart Association

  102
  0

Final ID:

Unveiling Novel Hepatic Metabolic Pathways as Dual Targets for MASH and Atherosclerosis Treatment

  • Rom, Oren  ( LSU Health Shreveport , Shreveport , Louisiana , United States )
    • Author Disclosures:
    Oren Rom: No Answer
Meeting Info:

Vascular Discovery Scientic Sessions 2025

2025

Baltimore, MD

Session Info:

07. Concurrent Session 2b: Metabolism in Cardiovascular Disease

Wednesday, 04/23/2025 , 03:30PM - 05:00PM

Oral

More abstracts on this topic:
Development of Photoactivable apoE for In Vivo Tracking

Strickland Michael, Soni Sahil, Randolph Gwendalyn

Hepatic Serine Hydroxymethyltransferase 2 Drives Atherosclerosis through One-Carbon Metabolic Regulation of VLDL and Ceramides

Richard Koral, Wei Bo, Mahmud Iqbal, Tan Lin, Orr Wayne, Yurdagul Arif, Mor Inbal, Lorenzi Philip, Gottlieb Eyal, Rom Oren, Ghrayeb Alia, Mckinney Mary, Finney Alexandra, Anand Sumit, Rohilla Sumati, Das Sandeep, Arias Bordajandi Fabio, Pearson-gallion Brenna

More abstracts from these authors:
Internet Addiction and Early-Life Risk Indicators for Cardiometabolic and Mental Health Disorders

Xing Diensn, Laird Colin, Bhuiyan Md Shenuarin, Rom Oren, Orr Wayne, Conrad Steven, Vanchiere John, Kevil Chris, Bhuiyan Mohammad

Hospitalizations for Metabolic Dysfunction-Associated Steatotic Liver Disease Among Patients with Different Cardiovascular Disease

Boullion Jolie, Kevil Chris, Bhuiyan Mohammad, Agrawal Akshat, Karzoun Zack, Boudreaux Porter, Rom Oren, Orr Wayne, Conrad Steven, Bhuiyan Md Shenuarin, Vanchiere John

You have to be authorized to contact abstract author. Please, Login
Not Available